All over the United States there has been a considerable amount of lawsuits that have been brought to court against the manufacturers of Zofran, GlaxoSmithKline. The filed cases disclose that Zofran, used for stopping nausea and vomiting in cancer patients going through chemotherapy and radiation therapy, as well as patients who would have undergone an operation, was wrongfully publicized as a morning sickness medication. Many pregnant women were since prescribed Zofran if they were suffering from persistent nausea and vomiting in their first three months of pregnancy. The makers of the drug misled patients into believing that the Zofran was safe enough for consumption while pregnant. However, GSK did not perform adequate tests to confirm the safety or lack thereof the drug on unborn babies.
Furthermore, GSK, pleaded guilty to illegally advertising Zofran usage for the prevention of morning sickness and paid a $3 billion fine. However, they have not conducted research of the unfavorable effects of Zofran on fetal development. There have been other studies conducted all over the world that aimed to know the effects Zofran had on an unborn child. The studies have revealed that taking Zofran in the first crucial three months of fetal development endanger the baby to end up being born with certain types of abnormalities such as cleft lip or cleft palate and hole in the heart defects. For more information about the studies go here.
New Mexico: Birth Deformities Data
New Mexico,tracks the rate of babies born with a birth defect. This rate is used to measure how often that birth defect happens; and is determined by counting how many times the birth defect happens in every 10,000 live births. Nationally, the estimate is that one in 33 babies is delivered with a birth deformity. From the time Zofran was accessible following its FDA authorization in 1991, it became the go to drug for multitudes of pregnant women who wanted relief from persistent morning sickness. The drug even held 99% market share in 2005. The number of people residing in New Mexico in accordance to census estimations is 2,085,572.
The five most highly populated cities in New Mexico have the following populations:
- Albuquerque- population 557,169
- Las Cruces- population 101,408
- Rio Rancho- population 93,820
- Santa Fe- population 70,297
- Roswell- population 48,608
Applying the Zofran market share data, our Zofran attorneys have processed information on the likely figures of births that could have been affected by the use of Zofran, and incorporated averaged potential hazards noted in the various medical studies carried out. We calculate an approximate 1,078 infant births in New Mexico that were negatively affected by Zofran’s presence in utero in the first three months of development.
New Mexico Probable Orofacial Cleft & CHDs Likely Linked To Zofran
From the time Zofran was introduced to the market, it had three patents that boosted Zofran to have total domination on the market until 2006. Generic versions since followed. If the ratios and estimations found in the Zofran related researches are valid, we assess a probable 1,078 birth deformities in New Mexico that were the result of having taken Zofran in the first three months of pregnancy. We further calculated which ones were some type of orofacial cleft and which ones were congenital heart defects (CHDs). The results were 196 orofacial cleft deformities and 882 CHDs. For the five major cities in New Mexico, individual break downs are as follows:
- Albuquerque- probable total birth deformities: 310 | likely orofacial cleft: 52 | likely CHDs: 258
- Las Cruces- probable total birth deformities:98 | likely orofacial cleft: 10 | likely CHDs: 88
- Rio Rancho- probable total birth deformities:94 | likely orofacial cleft: 9 | likely CHDs: 85
- Santa Fe- probable total birth deformities:83| likely orofacial cleft: 7 | likely CHDs: 76
- Roswell- probable total birth deformities:73| likely orofacial cleft: 5 | likely CHDs: 68
What Are The Birth Deformities And Negative Effects That Have Been Disclosed?
Current lawsuits have seen complainants disclose that Zofran was the source that caused their child to be born with major deformities. In all cases the mother had used Zofran to relieve severe morning sickness during the first three months of pregnancy. The complainants base their charges on several medical researches that have been carried out all over the world. It should be noted that regardless of these studies and lawsuits that proved the dangers Zofran causes on unborn babies, the manufacturers, GSK, deny that their drug is the dominant factor in the birth deformities occurring. Below are some of the birth defects that have been disclosed in filed cases:
- Congenital Abnormalities
- Kidney Malformations
- Cleft Palate
- Facial Dysmorphia
- Low Set Ears
- Club Foot
New Mexico Parents Looking For Justice
This website is funded by several law firms all in different geographical locations. The website is designed to be a resource that offers regular and timely information about the Zofran suit. Our Zofran attorneys are not authorized to practice law in the state of New Mexico, but, we are authorized and hold offices in the state of Delaware. Delaware is an essential state as it is where Zofran makers hold their main offices. This means we can stand up for your family’s legal rights for representation in a suit that is filed in Delaware.
To date, countless phone calls and contact forms have come our way from New Mexico families who suspect that their child’s birth deformity was induced by Zofran that was taken by the mom as an anti-morning sickness medication in the first three months of pregnancy. We evaluate each case individually in order to come up with the best method of filing your lawsuit. We may find it feasible to file your case in Delaware or another convenient location or filing in New Mexico using one of our known local legal counsel. Meet our Zofran legal team here.
You likely have many questions at this time, please do not hesitate to contact us. We are here to answer your questions at any time of the day.
Locating Orofacial Celft & CHDs Info In New Mexico
New Mexico Cleft Palate Center:
University Of New Mexico:
Eastern New Mexico Medical Center: